Levine Mitchell S 4
4 · OncoCyte Corp · Filed Dec 15, 2020
Insider Transaction Report
Form 4
Levine Mitchell S
Chief Financial Officer
Transactions
- Award
Common Stock
2020-12-11+10,121→ 46,700 total
Footnotes (1)
- [F1]The shares of the Issuer's common stock were issued to the Reporting Person for the repayment of deferred compensation in lieu of cash at a price of $2.07 per share.